Published 2 days ago • loading... • Updated 2 days ago

Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Next month, Scribe Therapeutics announced that Benjamin Oakes, Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference; the webcast will be archived for at least 30 days.
Co‑founded by Nobel Prize winner Jennifer Doudna, Scribe Therapeutics is backed by leading life sciences investors and collaborates with Sanofi and Eli Lilly to advance its CRISPR technologies.
The company's 'CRISPR by Design' platform engineers bacterial immune systems into genome and epigenome editing tools, aiming to improve activity, specificity, and deliverability, Scribe announced.
The webcast will be archived and available for replay for at least 30 days, and investors can access live and replay webcasts via investor‑relations pages, as the company said.
The platform could broaden therapeutic windows and enable preventative uses, potentially attracting further collaboration and investment, the company said.

Insights by Ground AI

16 Articles

Hanford Sentinel

+13 Reposted by 13 other sources

Center

GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Dec. 15, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 44th Annual J.P. Morgan…

2 days ago

Read Full Article